Results 91 to 100 of about 35,373 (217)

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity

Immunological Reviews, Volume 340, Issue 1, July 2026.
ABSTRACT Advances in high‐throughput sequencing, single‐cell profiling, and genome engineering have transformed the study of T cell receptors (TCRs), enabling the identification and functional interrogation of antigen‐specific repertoires at an unprecedented scale.
Kilian Schober
wiley   +1 more source

Yellow-fever vaccine associated serious adverse events during outbreak response vaccination in Brazil, 2008–2009.

, 2014
* Cases per million yellow fever vaccine doses administered during outbreak response.**Includes 22-day old infant with vaccine-associated neurologic disease following secondary transmission of yellow fever vaccine virus through breastfeeding [35].
Marco Antônio Barreto de Almeida (534771), Daniel Garkauskas Ramos (534768), Melissa Mascheretti (534773), Maria Auxiliadora Andrade (534769), Kátia Campomar Vettorello (534772), Brendan Flannery (352939), Alessandro Pecego Martins Romano (534766), Zouraide Guerra Antunes Costa (534767), Valéria de Sá Jayme (534770)   +8 more
core   +1 more source

Safety and tolerability of yellow fever vaccines [PDF]

, 2012
Yellow fever is a non-contagious, viral, multisystem syndrome, that causes an estimated 200 000 human infections annually, and has a high fatality rate. Yellow fever vaccination is one of the main methods of primary prevention. Although the yellow fever
Paul Rheeder, Makhunga-Ramfolo, Nondumiso Siphosakhe, Rheeder, Paul, Nondumiso Makhunga-Ramfolo   +3 more
core   +1 more source

RNF213 Is an Interferon‐Stimulated Gene That Targets Influenza A Virus NP and Activates MDA5 to Restrict Infection

Advanced Science, Volume 13, Issue 31, 4 June 2026.
RNF213 is characterized as a dual‐functional antiviral effector. It directly mediates the degradation of the influenza A virus nucleoprotein (NP) while simultaneously activating the MDA5‐mediated innate immune signaling pathway. This coordinated response establishes a powerful host defense system against viral infection. ABSTRACT Influenza A virus (IAV)
Haoning Li, Yuying Zhang, Jingjing Wang, Qianqian Zhang, Hailiang Sun, Fanhua Wei   +5 more
wiley   +1 more source

Yellow Fever Vaccine : Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002 [PDF]

This report updates CDC's recommendations for using yellow fever vaccine (CDC. Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunizations Practices: MMWR 1990;39[No. RR-6]1-6).

core  

Co‐infection of Hepatitis A and E With Atypical Manifestation: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Hepatitis A virus (HAV) and hepatitis E virus (HEV) are common causes of acute viral hepatitis in developing countries where inadequate sanitation and contaminated water supplies facilitate fecal–oral transmission. Although both infections are usually self‐limiting, co‐infection may result in atypical presentations and pose diagnostic ...
Umaimah Batool Mirza, Habib Ul Rahman Kalhoro, FNU Umna, Ahmed Asad Raza, Abedin Samadi   +4 more
wiley   +1 more source

Yellow Fever Vaccine; Recommendations of the Advisory Committee on Immunization Practices (ACIP) [PDF]

"This report updates CDC's recommendations for using yellow fever (YF) vaccine (CDC. Yellow fever vaccine: recommendations of the Advisory Committee on Immunizations Practices: MMWR 2002;51[No. RR-17]).

core  

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins

, 2006
The Yellow Fever Vaccine 17D (YFV17D) has been used as a vector for the Lassa virus glycoprotein precursor (LASV-GPC) resulting in construction of YFV17D/LASV-GPC recombinant virus.
Patterson, Jean, Spaan, Willy J.M., Ticer, Anysha, Lukashevich, Igor S., Molenkamp, Richard, Moshkoff, Dmitry, Tikhonov, Ilia, Salvato, Maria S., Deubel, Vincent, Zapata, Juan, Carrion, Ricardo, Marianneau, Phillippe, Brasky, Kathleen, Bredenbeek, Peter J.   +13 more
core   +1 more source

EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL.
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P. Kater, Carsten U. Niemann, Sarka Pospisilova, Tadeusz Robak, Anna Schuh, Kostas Stamatopoulos, Tamar Tadmor, Nick York   +13 more
wiley   +1 more source

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

, 2015
Background The yellow fever vaccine is regarded as one of the safest attenuated virus vaccines. with few side-effects or adverse events. We report the occurrence of two fatal cases of haemorrhagic fever associated with yellow fever 17DD substrain vaccine
Silva, LJ, Rodigues, SG, Costa, ZG, Sato, HK, Luna, EJ, Santos, CLS, Santos, RTM, Vasconcelos, PFC, Galler, R, Oliva, OFP, Lacava, E, Papaiordanou, CMO, Vilela, MFG, Alves, VAF, Andrade, LD, Coimbra, TL, Monath, TP, Froguas, GB, Laval, C, Cruz, ACR, Rosa, EST, Almeida, LMR, Rocco, IM, Barros, VLRS   +23 more
core   +1 more source